Ebtisam S. S. Al-Mizyen, M.B. Ch.B., M. Phil. * Jurgis G. Grudzinskas, M.D., F.R.C.O.G., F.R.A.C.O.G., B.Sc., M.B., B.S.

Similar documents
The prevalence of polycystic ovaries in healthy women

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary

Hum. Reprod. Advance Access published April 7, 2004

A prospective study comparing unilateral and bilateral laparoscopic ovarian diathermy in women with the polycystic ovary syndrome

Key words: laparoscopic ovarian multiple punch resection, laparoscopic ovarian electrocautery, infertility,

In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome

Gonadotrophin treatment in patients with Polycystic Ovary Syndrome

clinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome

Fertility preserving surgeries in PCOS: PCO Drilling

Diagnostic laparoscopy in primary and secondary infertility

Poly cystic ovary syndrome: the spectrum of the disorder in 1741 patients

Neil Goodman, MD, FACE

Ultrasonographic patterns of polycystic ovaries: color Doppler and hormonal correlations

Maternity and Child Healthcare Hospital, Shen-Zhen, People s Republic of China

usually, but not always, enlarged.' These are features that can be identified using high resolution ultrasonography of the ovaries.

The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology

LUTEINIZED UNRUPTURED FOLLICLE SYNDROME: A SUBTLE CAUSE OF INFERTILITY*

Ovarian Drilling Efficacy, Estradiol Levels and Pregnancy Rate in Females With Polycystic Ovary Syndrome

The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (1), Page 63-69

Infertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations

Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome

Uterus & Ovary 2015; 2: e904. doi: /uo.904; 2015 by Ahmed M Maged, et al.

In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome

Original Article. Fauzia HaqNawaz 1*, Saadia Virk 2, Tasleem Qadir 3, Saadia Imam 3, Javed Rizvi 2

Bulent Urman, M.D.* Margo R. Fluker, M.D. Basil Ho Yuen, M.B., Ch.B.t

Serum Vascular Endothelial Growth Factor in Polycystic Ovary Syndrome and its Relation to Ovarian Drilling

Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

Department of Obstetrics and Gynecology, Benha Faculty of Medicine, Benha University, Egypt

Nazanin Farshchian, Siavash Teimuri Nezhad, and Parisa Bahrami Kamangar RESEARCH ABSTRACT. What this study adds: Background

EVALUATING THE INFERTILE PATIENT-COUPLES. Stephen Thorn, MD

Characterization of Normal and Polycystic Ovaries Using Three-Dimensional Power Doppler Ultrasonography

Polycystic Ovary Syndrome (PCOS):

New York Science Journal 2017;10(8)

Relation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy

The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria

Approach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD

Letrozole versus Clomiphene Citrate in Patients with Anovulatory Infertility

What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...

Clinical study of polycystic ovarian syndrome (PCOS) in tertiary care centre

Infertility for the Primary Care Provider

New PCOS guidelines: What s relevant to general practice

ORIGINAL ARTICLE Reproductive endocrinology

INFERTILITY CAUSES. Basic evaluation of the female

Prevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study

Department of Obstetrics and Gynecology, School of Medicine, Ewha Womans University, Seoul, Korea

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman

Polycystic ovary syndrome: it is always bilateral?

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome

Understanding Infertility, Evaluations, and Treatment Options

Nature and Science 2017;15(8)

Infertility: A Generalist s Perspective

Clinical Study and Outcome of Polycystic Ovarian Syndrome

Standards for ovarian volume in childhood and puberty*

Can Sex hormone Binding Globulin Considered as a Predictor of Response to Pharmacological Treatment in Women with Polycystic Ovary Syndrome?

Endometrial blood flow response to hormone replacement therapy in women with premature ovarian failure: a transvaginal Doppler study

Polycystic Ovary Syndrome

NaProTechnology. An Integrated Approach to Infertility. Tracy Parnell. Geneva 2005

Nitasha Garg 1 Harkiran Kaur Khaira. About the Author

Imaging in Pediatric and Adolescent Gynecology

INFERTILITY: DIAGNOSIS, WORKUP AND MANAGEMENT FOR THE COMMUNITY PHYSICIAN

3. Metformin therapy for PCOS

Original Article. Mervat Mohamed Harira

F REQUENTLY A SKED Q UESTIONS

Surgical treatment of PCOS 2017 status. Professor Gab Kovacs AM Professor of O & G, Monash University Director, O & G Institute, Epworth Healthcare

Infertility Investigations. Patient Information

Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance related polycystic ovary syndrome

Polycystic Ovarian Syndrome (PCOS) LOGO

PCOS guidelines: What s relevant to general practice

Diagnostic L/S: Is it ever indicated? Prof. Dr. Nilgün Turhan Fatih University Medical School

Reproductive Testing: Less is More G. Wright Bates, Jr., M.D. Professor and Director Reproductive Endocrinology and Infertility Objectives

Index. Note: Page numbers of article titles are in boldface type.

Achieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center

Infertility DR. RAHUL BEVARA

Indian Journal of Basic and Applied Medical Research; September 2015: Vol.-4, Issue- 4, P

JMSCR Vol 3 Issue 10 Page October 2015

Fertility Treatment: Do not be Distracted

Dr Manuela Toledo - Procedures in ART -

The basic fertility workup in women with polycystic ovary syndrome: a systematic review

Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?

Original Research Article

Polycystic Ovary Syndrome

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

Journal of American Science 2013;9(12)

Results of microsurgical reconstruction in patients with combined proximal and distal tubal occlusion: double obstruction

Infertility History Form

Smita Jain, M.B., M.S.* and Maureen E. Dalton, F.R.C.O.G. Sunderland Royal Hospital, Sunderland, Tyne and Wear, United Kingdom

AIMS To evaluate the effectiveness and safety of laparoscopic ovarian drilling compared with ovulation induction for clomiphene-resistant PCOS.

Ovarian response after laparoscopic ovarian cystectomy for endometriotic cysts in 132 monitored cycles

Risk factors for spontaneous abortion in menotropintreated

Hyperinsulinemia is common in family members of women with polycystic ovary syndrome*

Commissioning Brief - Background Information. Letrozole for improving fertility in women with polycystic ovary syndrome

THYROID PROFILE IN POLYCYSTIC OVARIAN SYNDROME Sudhanshu Sekhara Nanda 1, Subhalaxmi Dash 2, Ashok Behera 3, Bharati Mishra 4

Overview of Reproductive Endocrinology

Realizing dreams booklet.indd 1 5/20/ :26:52 AM

Ovarian response in three consecutive in vitro fertilization cycles

Fertility Assessment and Treatment Pathway

Hormonal Changes After Laparoscopic Ovarian Diathermy in Patients with Polycystic Ovarian Syndrome

BACKGROUNDER. Pregnitude A Fertility Dietary Supplement for Reproductive Support Offers an Additional Option for Women Who Are Trying to Conceive

Transcription:

Middle East Fertility Society Journal Vol. 12, No. 3, 27 Copyright Middle East Fertility Society Ultrasonographic observations following unilateral and bilateral laparoscopic ovarian diathermy in infertile women with clomiphene citrate resistant polycystic ovarian syndrome (PCOS) Ebtisam S. S. Al-Mizyen, M.B. Ch.B., M. Phil. * Jurgis G. Grudzinskas, M.D., F.R.C.O.G., F.R.A.C.O.G., B.Sc., M.B., B.S. * Department of Obstetrics and Gynecology St Bartholomew's and The Royal London School of Medicine and Dentistry, London, Queen Mary's Hospital, Roehampton, The London Bridge Fertility, Gynecology and Genetics Centre, London, UK ABSTRACT Objective: To evaluate the changes in ovarian volume and the reproductive outcome after unilateral (UOD) and bilateral (BOD) laparoscopic ovarian diathermy in infertile women with Clomiphene Citrate resistant PCOS. Material and Methods: The ovarian volume in both groups was measured by transvaginal ultrasonography preoperatively and up to 1 days after laparoscopic ovarian diathermy and examined in relation to the subsequent clinical course. Results: Of the ten patients who underwent UOD, seven clinical pregnancies were achieved in five women. Of the ten patients who underwent BOD, seven clinical pregnancies were achieved in six women. BOD was seen to be followed by a statistically significant decrease in mean ovarian volume ten days post-operatively; whilst there were no changes in mean ovarian volume following UOD, resulting there was a decrease in ovarian volume in two women whose right ovary (ipsilateral) was diathermied and three women in the contralateral ovary. Conclusion: Although such changes were not consistently seen following UOD, the clinical outcome was similar in both groups. Key words: unilateral vs. bilateral laparoscopic ovarian diathermy; polycystic ovarian syndrome; ultrasound The cornerstone of the definition of PCOS is the ultrasonographic ovarian appearance of the polycystic ovary coupled with menstrual disturbance, hyperandrogenism and anovulation (1-3). Furthermore, since the introduction of realtime ultrasonography, polycystic ovaries have been found in about 2% of normal female volunteers (4-6), typically observed as the presence of ten or * Department of Obstetrics and Gynecology St Bartholomew's & The Royal London School of Medicine & Dentistry, London EC1A 7BE, Queen Mary's Hospital, Roehampton, SW1 PN, The London Bridge Fertility, Gynecology and Genetics Centre, 1 St Thomas St, London SE1 9RY. Corresponding author: Dr Ebtisam Suliman Al-Mizyen. Queen Mary's Hospital, Roehampton, SW1 PN, Email: drebtisam@hotmail.com more cysts measuring 2-8 mm in diameter, arranged peripherally around a dense core of stroma or scattered throughout an increased amount of stroma (1). With the advent of high frequency transvaginal probes placed in close proximity to the pelvic organs, image resolution and anatomical detail have improved markedly leading to transvaginal ultrasonography (TVS) becoming established as the diagnostic tool of choice for ovarian morphological assessment in the diagnosis of polycystic ovarian syndrome. An early study reported a transient increase in ovarian size after laparoscopic ovarian diathermy due probably to inflammatory changes, but three weeks later the average volume was seen to be significantly smaller (7). More recently, long-term Vol. 12, No. 3, 27 Al-Mizyen and Grudzinskas Ultrasound measurements after ovarian diathermy 27

follow up at medium-term and long-term intervals confirmed that ovarian volume decreased significantly from 11. cc before laparoscopic ovarian diathermy (LOD) to 8. cc at medium-term and remained low 8.4 cc at long-term follow up (8). The purpose of the current study was to determine the effect of laparoscopic unilateral and bilateral ovarian diathermy on ovarian volume and subsequently reproductive outcome. MATERIAL AND METHODS All the patients were recruited from the Gynecology Department or the Centre for Reproductive Medicine at St Bartholomew's and the Royal London Hospitals over a three-year period. Women with anovulatory infertility due to Clomiphene Citrate resistant PCOS were recruited to be randomly allocated according to cards numbered, one to twenty, in sealed envelopes to either unilateral (right ovary, only) (even number, n=1) or bilateral (odd number, n=1) laparoscopic ovarian diathermy after informed written consent in this study which had been approved by the East London, City & Hackney Authority (ELCHA) Research Ethics Committee. Clomiphene Citrate resistance was defined as failure to ovulate after Clomiphene Citrate administration up to a daily dose of 1 mg from cycle days 2-6 for at least three consecutive cycles. Criteria for inclusion were: 1) age between 2 and 38 years; 2) body mass index<28 Kg/m 2 ; 3) history of infertility; 4) diagnosis of PCOS using the National Institutes of Health (NIH) criteria based on (a) amenorrhea or oligomenorrhea with chronic anovulation, (b) clinical and/or biochemical evidence of hyperandrogenism (9,1), (c) ultrasonographic appearance of PCOS was defined as an increase in ovarian volume, more than ten follicles of 3-8 mm in diameter and an increase in stromal density (1). All women were normo-prolactinemic, normotensive, and had no evidence of any other medical disorder. Thyroid function, blood glucose and 17αhydroxyprogesterone levels were normal between (1-1 nmol/l). All women had at least one patent Fallopian tube. After randomization, ten patients underwent unilateral laparoscopic ovarian diathermy always on the right ovary and ten had bilateral ovarian diathermy using the laparoscopic technique described (11). The procedure was always conducted by either the two authors or a senior registrar in the presence of one of the authors to ensure that the same technique was used in each patient. Laparoscopy was performed under general anesthesia with endotracheal intubation. The laparoscope was introduced subumbilically and trocars and cannulae were introduced into the iliac fossae for forceps to hold the ovarian ligament and the diathermy probe. After careful inspection of the pelvic organs, tubal patency was confirmed by transcervical injection of methylene blue dye. The ovary was lifted to the anterior wall of the uterus to minimize the likelihood of damage to neighboring viscera during unipolar diathermy (G U Turner Warwick, London, UK). The machine was set on 4 watts and diathermy applied using a specially designed probe, at four points, for 4-6 seconds at each point. Craters created were ~3-4 mm in diameter and ~8 mm in depth. The electrosurgical unit employed was the Force 2 Valleylab electrosurgical generator (Valleylab Inc, Boulder, Co, USA). The ovary was then cooled with normal saline, to minimize adhesion formation and to prevent heat trauma to adjacent viscera. The saline (3 ml) was left in the peritoneal cavity at the end of the procedure. All patients underwent a transvaginal ultrasound examination up to 1 days prior to and ten days after surgery performed by the author (vaginal probe, 6. MHz transducer, Toshiba, Japan) to assess the ovarian volume and morphology and to monitor the evidence of ovulation at each visit to the clinic. Ovulation confirmed by serum progesterone levels and transvaginal ultrasonography (TVS) observations i.e. follicle collapse and elevated serum progesterone level 7 days later. All ultrasound follow-up examinations were performed vaginally by the author to examine the uterus, ovaries and adnexal structures and, at the same time, to monitor for evidence of ovulation at each visit to the clinic using the technique described above. was calculated using this formula: Volume (ml) = length (cm) X width (cm) X depth (cm) X.233. 28 Al-Mizyen and Grudzinskas Ultrasound measurements after ovarian diathermy MEFSJ

2 2 1 1 Figure 1. Pre and postoperative (mean ±SD) ovarian volume in the right ovary following unilateral ovarian diathermy (n=1 women). Venous blood was obtained preoperatively, postoperatively and 1 days intervals until menstruation occurred from the majority of patients. This analysis is the subject of other report (12). The statistical analyses are expressed by mean ± SD, the differences seen being statistically significant if P <., using paired Student's t-test. RESULTS Measurement of ovarian volume in the unilateral group (n=1) revealed that the mean pre-operative volume of the right ovary was 13.7±3. cc, being unchanged ten days after surgery, 13.6±4. cc (p=.98, NS). Similar results were obtained with respect to the left ovary, the mean pre-operative volume being 11.9±2.6 cc and mean post-operative volume being 1.±3.2 cc (p=.21, NS). By contrast, in the bilateral group (n=1), there was a statistically significant reduction in mean ovarian volume in both right and left ovaries. The mean pre-operative volume of the right ovary was 1.7±4.8 cc while, ten days after surgery; it was 1.1±3.2 cc (p=.1). Similar results were obtained for the left ovary, the mean pre-operative volume being 14.6±.2 cc and mean post-operative 9.2±3.7 cc (p=.1). (Tables 1-2; Figs.1-4). All women were followed up at regular monthly intervals for up to 18 months after surgery. The recall follow-up was at 18-48 months after UOD and BOD, the 2 women being recalled for early follicular phase hormonal tests and ultrasound. Spontaneous menstruation had occurred in a similar number of women in each group (unilateral, %; bilateral, 4%), there being similar observations between the unilateral and bilateral groups with respect to spontaneous ovulation ( 2% vs. 1%), Table 1. measurements (mean±sd) pre- and post-operatively after unilateral ovarian diathermy (n=1) (cc) Pre-operative P value * Right ovary 13.7±3. 13.6±4. NS Left ovary 11.9±2.6 1.±3.2 NS * P value using paired Student's t-test Table 2. measurements (mean±sd) pre- and post-operatively after bilateral ovarian diathermy (n=1) (cc) P value * Right ovary 1.7±4.8 1.1±3.2.1 Left ovary 14.6±.2 9.2±3.7.1 * P value using paired Student's t-test Vol. 12, No. 3, 27 Al-Mizyen and Grudzinskas Ultrasound measurements after ovarian diathermy 29

2 2 1 1 Figure 2. Pre and postoperative (mean ±SD) ovarian volume in the left ovary following unilateral ovarian diathermy (n=1 women). amenorrhea whilst breast feeding (2% vs. 2%), secondary amenorrhea i.e., menstruation had occurred in the past but not for at least six months (3% vs. %) and pregnancy (7% vs. 7%) respectively (Table 3). After ovarian diathermy seven pregnancies were achieved in five women after UOD in contrast to seven pregnancies in six women after BOD. These pregnancies were consequent to spontaneous menstruation in nine women in each group, spontaneous ovulation (in two women after UOD vs. one woman after BOD) and Clomiphene Citrate induced ovulation (four women after UOD vs. five women after BOD). Clomiphene Citrate resistance was noted to persist in four women in each group. One of these three women after UOD, responded to HMG and conceived, while the other four Clomiphene Citrate resistant women after BOD declined to have further treatment. Table 3. Reproductive outcome up to 48 months after surgery in women who had undergone unilateral (n=1) and bilateral (n=1) ovarian diathermy Outcome measure Unilateral n=1 women Pregnancy 7 * 7 Live birth 6 Miscarriage 2 1 * Two women conceived twice One woman conceived twice Bilateral n=1 women In the five women who conceived following UOD, the ovarian volume of the right ovary decreased in two women and increased in the remaining. In the contralateral ovary the ovarian volume decreased in three women and was unchanged in two. By contrast, in all six women who conceived following BOD, changes in ovarian volume were seen. The ovarian volume in the right ovary decreased in five women and increased in one woman, whilst in the contralateral ovary there was a decrease in ovarian volume in six women. DISCUSSION One of the effects of laparoscopic ovarian diathermy is reduction of ovarian volume. There are, however, very limited data from one group documenting the quantitative changes in ovarian volume following ovarian diathermy, in association with the reproductive outcome. They reported a transient increase in volume after laparoscopic ovarian diathermy due probably to inflammatory changes, but three weeks later the average volume was significantly smaller (7). In our study, women who underwent bilateral ovarian diathermy had a statistically significant reduction in mean ovarian volume seen in both ovaries 1 days post-operatively. By contrast, women in the unilateral diathermy group did not show any change in mean ovarian volume in either 21 Al-Mizyen and Grudzinskas Ultrasound measurements after ovarian diathermy MEFSJ

2 2 1 1 Figure 3. Pre and postoperative (mean ±SD) ovarian volume in the right ovary following bilateral ovarian diathermy (n=1 women). ovary. It was surprising to note a similar clinical outcome with respect to pregnancy rates in particular, in both groups. We showed that the ovarian volume decreased ten days postoperatively, in contrast to the increase in the ovarian volume seen by others one week postoperatively (7). These differences may due to study design and duration of diathermy, yet in spite of the different techniques used, the clinical outcome was similar on both studies. A recent long-term follow up at medium-term and long-term intervals confirmed that ovarian volume decreased significantly from 11. cc before LOD to 8. cc at medium-term and remained low 8.4 ml at long-term follow up (8). More studies are needed to determine whether there is a relationship between the changes in ovarian volume and the endocrine profile after diathermy. In conclusion we found that bilateral laparoscopic ovarian diathermy was seen to be followed by a decrease in ovarian volume ten days post-operatively in six women. This decrease was seen in two women whose right ovary was diathermied in the UOD group and three women in the contralateral ovary. The clinical outcome was similar in both groups. 2 2 1 1 Figure 4. Pre and postoperative (mean ±SD) ovarian volume in the left ovary following bilateral ovarian diathermy (n=1 women). Vol. 12, No. 3, 27 Al-Mizyen and Grudzinskas Ultrasound measurements after ovarian diathermy 211

REFERENCES 1. Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, Morris DV, Price J, Jacobs HS. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 198; 2: 137-1379. 2. Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 6 patients. Clinical Endocrinology 198; 3:49-47. 3. Battaglia C, Regnani G, Artini PG, Giulini S, Genazzani AD, Genazzani AR, Volpe A. Polycystic ovary syndrome: a new ultrasonographic and color Doppler pattern. Gynecological Endocrinololgy 2; 14:417-424. 4. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries - a common finding in normal women. Lancet 1988; 1:87-872.. Clayton RN, Ogden V, Hodgkinson J, Worswick L, Rodin D, Dyer S, Meade TW. How common are polycystic ovaries in normal women and what is their significance for the infertility of the population? Clinical Endocrinology 1992; 37:127-134. 6. Abdel Gadir A, Khatim MS, Mowafi RS, Alnaser HM, Muharib NS, Shaw RW. 1992. Implication of ultrasonically diagnosed polycystic ovaries. 1. Correlation with basal hormonal profiles. Hum Reprod 1992; 4:43-47. 7. Tulandi T, Watkin K, Tan SL. Reproductive performance and three-dimensional ultrasound volume determination of polycystic ovaries following laparoscopic ovarian drilling. International Journal of Fertility and Women s Medicine 1997; 42:436-44. 8. Amer SA, Banu Z, Li TC and Cooke ID. 22. Long term follow-up of patients with polycystic ovary syndrome after laparoscopic ovarian drilling: endocrine and ultrasonographic outcome. Hum Reprod 22; 7:281-287. 9. Zawadski Jk and Dunaif A. Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In: Polycystic Ovary Syndrome, edited by Dunaif A, Givens JR and Haseltime F., 1992; pp. 377-384. Blackwell Scientific, Boston. 1. Azziz R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil Steril 2;83:1343-1346. 11. Armar NA and Lachelin GC. Laparoscopic ovarian diathermy: An effective treatment for anti-estrogen resistant anovulatory infertility in women with polycystic ovary syndrome. British J Obstet Gynaecol 1993; 1: 161-164. 12. Al-Mizyen E and Grudzinskas JG. Unilateral laparoscopic ovarian diathermy in infertile women with Clomiphene Citrate resistant polycystic ovarian syndrome (PCOS). Fertil Steril 27 Apr 2; [Epub ahead of print] PMID: 1741693 Received on March 19, 27; revised and accepted on June, 27 212 Al-Mizyen and Grudzinskas Ultrasound measurements after ovarian diathermy MEFSJ